Evommune, Inc. (EVMN)
NYSE: EVMN · Real-Time Price · USD
20.69
+0.20 (0.98%)
Jun 11, 2026, 4:00 PM EDT - Market closed
Evommune Market Cap
Evommune has a market cap or net worth of $745.22 million as of June 12, 2026.
Market Cap
745.22M
Enterprise Value
542.87M
1-Year Change
n/a
Ranking
Category
Stock Price
$20.69
Market Cap Chart
Since the IPO on November 6, 2025, Evommune's market cap has increased from $481.24M to $745.22M, an increase of 54.85%. That is a compound annual growth rate of 108.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 11, 2026 | 745.22M | 38.08% |
| Dec 31, 2025 | 539.69M | 12.15% |
| Nov 6, 2025 | 481.24M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ORIC Pharmaceuticals | 780.52M |
| Phathom Pharmaceuticals | 780.00M |
| Inventiva | 779.95M |
| Annexon | 773.34M |
| Kura Oncology | 770.56M |
| Odyssey Therapeutics | 764.22M |
| Cullinan Therapeutics | 740.57M |
| Omeros | 738.23M |